Skip to main content
. 2021 Mar 14;13(6):1292. doi: 10.3390/cancers13061292

Figure 2.

Figure 2

Specificity of various types of BCl-2 inhibitors and induction of apoptosis. Targeting the Bcl-2 pro-survival proteins by various inhibitors with different specificity (ABT-737/ABT-263, obatoclax, or venetoclax) leads to BAX/BAK activation and pores formation through which cytochrome c is released into the cytosol culminating in apoptosis induction.